Here are three notes:
1. The type of COVID-19 vaccine may affect breakthrough infection risk. A Mayo Clinic Health System study showed people who received the Moderna vaccine may be less likely to experience a breakthrough infection when compared with the Pfizer vaccine. The Rochester, Minn.-based health system found Moderna’s vaccine 76 percent effective, while the Pfizer vaccine was 46 percent effective in preventing breakthrough infections.
Click here to read more.
2. Arkansas had the highest rate of breakthrough COVID-19 hospitalizations as of Aug. 11. Around 4.7 percent of COVID-19 hospitalizations in Arkansas were breakthrough cases. Maine had the highest rate of COVID-19 deaths among fully vaccinated individuals at 5.6 percent of COVID-19 deaths. The data is based on a report from The New York Times with information from 40 states and Washington, D.C.
Click here to read more.
3. An article in Scientific American noted that although breakthrough cases of COVID-19 are occurring, that doesn’t mean the vaccines don’t work. The shots provide protection against serious illness and make it more difficult for infected people to transmit the disease.
Click here to read more.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.